Susan Hasty, Publisher
Table of Contents . . . January 19th, 2006
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Medical Verdicts and Law Weekly | Other Publications
Alethia BioTherapeutics, Inc. - Patent application filed for bone-related validated targets
Alliance for Stem Cell Research - Stem cell research organization endorses proposed Missouri initiative
BioCryst Pharmaceuticals, Inc. - Hart-Scott-Rodino waiting period terminated early for the Roche license of BCX-4208
Cellectis SA - License agreement signed with AstraZeneca covering the use of homologous recombination
Cellectricon - Systems launched for adherent cell electroporation
Cepheid - New patents awarded for ultrasonic lysis and sample preparation technology
Collaborations - American Healthways to provide disease management services to BCBS Northern Plains Alliance
Community Bank, N.A. - Health savings accounts become more available
Competitive Technologies - Homocysteine assay license granted to Genzyme Diagnostics
CuresNow - Missouri Stem Cell Research and Cures Initiative gets solid endorsement
Cutting Edge Information - Blockbuster drugs' market share in danger
Diomed Holdings, Inc. - AngioDynamics and Vascular Solutions face motion for summary judgment
Drug Importation - Study shows Canadian drugs are more affordable than Medicare Part D
Federated Ambulatory Surgery Association - HHS Secretary and Senator Crapo lauded for commitment to expand access to ASCs
Frost & Sullivan Media - Patent expiry offers exciting growth opportunities
- Increasing number of coronary artery bypass grafts for women may result in burdensome cost
Aastrom Biosciences, Inc. - Positive human jaw bone reconstruction results reported from feasibility clinical trial
Abbott - ATLAS study shows improvement in quality of life for ankylosing spondylitis patients taking Humira
Abiomed, Inc. - Daniel Sutherby named chief financial officer at cardiac device company
Acologix, Inc. - Bone and kidney disease-focused company closes $25M series C financing
Actavis Group - Generic pharmaceutical firm completes acquisition of Alpharma's human generics business
Advanced Biotherapy, Inc. - Arthritis drug developer appoints Daniel Levitt to scientific advisory board
Advanced Chemistry Development, Inc. - Firms announce availability of Metabolite Database for labs
Advocate Christ Medical Center, Oak Lawn - Pelvic organ prolapse in women leads to reduced expression of lysyl oxidase
Affymetrix, Inc. - SNP panels launched for targeted genotyping applications
All Children's Hospital, St. Petersburg - Ex vivo system promotes stem-like cell trafficking from ventricles to culture surface
All India Institute of Medical Sciences - Latex of Calotropis procera was comparable to glibenclamide as antidiabetic agent
American Chemistry Council - Chemical makers work with Congress on security legislation
American Society for Aesthetic Plastic Surgery - Cosmetic plastic surgery predictions for 2006 issued
Amgen - Metabolism-focused biotech company to acquire Abgenix for $2.2 billion
Amylin Pharmaceuticals, Inc. - James Gavin elected to board of directors at company developing diabetes therapies
Anachem - Collaboration will bring new line of membrane technology products to U.K. and Ireland
Anachem - Medical device company expands range of serological pipettes
Anadys Pharmaceuticals, Inc. - Two executive advances reported at pharmaceutical firm developing hepatitis therapy
AngioDynamics, Inc. - New catheter launched to percutaneously drain abscesses
Anxiety Disorders - Association presents guidelines for the diagnosis and treatment of anxiety
Astellas Pharma U.S., Inc. - U.S. subsidiary of Japanese pharma firm appoints new R&D head
Australia Commonwealth Scientific & Industrial Research Org. - Weight loss did not improve flow-mediated dilatation
Avalon Pharmaceuticals, Inc. - Avalon Pharmaceuticals announces expiration of the sanofi-aventis agreement
Axis-Shield - Agreement signed to develop market tests on Abbott's Architect System
BTE Technologies, Inc. - New multi-cervical unit device launched for neck pain
Bayer Pharmaceuticals Corp. - Phase III study of Trasylol in elective spinal fusion surgery launched
Best Practices, LLC - Research shows forward-looking companies build organizational capabilities to manage speakers
Boston University - Higher doses of cidofovir may be safe to treat recurrent respiratory papillomatosis
Boston University - Hypoxia suppresses elastin repair in rat lung fibroblasts
Boston University - Researchers' findings advance Obesity Pathogenesis research
Brighton & Sussex University Hospital - HIV infection significantly reduces survival rate of patients with tuberculous meningitis
Brighton University - Gender differences in response to lorazepam treatment reported
Burnham Institute, La Jolla - Reports advance knowledge in HIV/AIDS Pathogenesis research
CalbaTech, Inc. - Solana MedSpas reaches agreement to exclusively offer LifeStem's stem cell microbank service
Cambrex Corporation - Dowpharma contracts first partner for use of Pfenex expression technology
Canberra Hospital - NSE and S100B levels correlated with hypoxia outcome in neonatal pigs
Cancer Therapy - Dendritic cell therapy arrests carbonic anhydrase II activity in tumor vessels
Candela Corporation - Intense pulsed light system gets FDA clearance
Capital University of Medical Science, Beijing - Diffusion tensor tractography used for neurosurgical planning
Caprion Pharmaceuticals Inc. - Antibodies win European and U.S. orphan drug status
Cardiff Research Consortium - Orlistat appeared to reduce need for additional diabetes drugs regardless of weight loss
Cardiology - Heartfelt wake-up call sounded for heart attack survivors
Catholic University, Rome - Low 25(OH)D does not affect insulin sensitivity in obesity after bariatric surgery
CeNeRx BioPharma, Inc. - Central nervous system-focused biopharma firm appoints chief medical officer
Celerus Diagnostics - Cancer diagnostics company completes initial financing round
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.